在一项新的研究中，来自南卡罗来纳医科大学霍林斯癌症中心的研究人员揭示了如何设计嵌合抗原受体（chimeric antigen receptor, CAR）Treg细胞的新规则。这一突破可能为对抗1型糖尿病等自身免疫性疾病提供更有效的工具。

AstraZeneca has selected a candidate to progress in the type 1 diabetes (T1D) Treg cell therapy programme, as per an 18 November press release. It is the first asset licensed by the British big ...

Although targeting Tregs to restore anti-tumor immunity is an emerging area in cancer therapy, systemically inhibiting Tregs ...

an area of therapeutics development that is viewed as being at the forefront of extending the role of cell therapy beyond cancer. As their name suggests, Treg cells play a key role in controlling ...

Gdańsk, Poland – 16 September 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG) , a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases, today ...

Coya Therapeutics advances COYA 303 for inflammatory diseases, combining COYA 301 and GLP-1 RA for a synergistic anti-inflammatory effect.